Patients With Coronary Microvascular Dysfunction Have Less Circulating α-Klotho.
Nadia AkhiyatIlke ÖzcanRajiv GulatiAbhiram PrasadTamara TchkoniaJames L KirklandBradley R LewisLilach Orly LermanAmir LermanPublished in: Journal of the American Heart Association (2024)
Klotho may be a biomarker for CMD and may be a therapeutic target for groups of patients without significant traditional cardiovascular risk.